HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Nadine Bakkar Selected Research
Nadine Bakkar Research Topics
Disease
5
Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2024 - 07/2015
2
Disease Progression
01/2022 - 05/2015
2
Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
01/2018 - 04/2007
1
TDP-43 Proteinopathies
01/2024
1
Alzheimer Disease (Alzheimer's Disease)
01/2023
1
Atrophy
01/2022
1
Hepatolenticular Degeneration (Wilson's Disease)
01/2021
1
Occipital horn syndrome
01/2021
1
Menkes Kinky Hair Syndrome (Menkes Disease)
01/2021
1
Motor Neuron Disease (Primary Lateral Sclerosis)
01/2021
1
Neurodevelopmental Disorders
01/2021
1
Neurodegenerative Diseases (Neurodegenerative Disease)
01/2018
1
Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
09/2015
1
Neoplasms (Cancer)
07/2013
1
Lymphoma (Lymphomas)
07/2013
1
Sarcoma (Soft Tissue Sarcoma)
07/2013
1
Hypertrophy
02/2010
1
Muscular Dystrophies (Muscular Dystrophy)
04/2007
1
Necrosis
04/2007
1
Inflammation (Inflammations)
04/2007
1
Status Epilepticus (Complex Partial Status Epilepticus)
04/2004
Drug/Important Bio-Agent (IBA)
2
Biomarkers (Surrogate Marker)
IBA
01/2022 - 05/2015
2
RNA-Binding Proteins (RNA-Binding Protein)
IBA
01/2018 - 09/2015
2
Proteins (Proteins, Gene)
FDA Link
09/2015 - 07/2013
2
NF-kappa B (NF-kB)
IBA
02/2010 - 04/2007
1
DNA-Binding Proteins (DNA Binding Protein)
IBA
01/2024
1
alpha-Synuclein
IBA
01/2024
1
Cytokines
IBA
01/2023
1
Copper Transport Proteins
IBA
01/2021
1
Copper
IBA
01/2021
1
Calcium
IBA
01/2018
1
Protein S
IBA
09/2015
1
Antioxidants
IBA
07/2015
1
Messenger RNA (mRNA)
IBA
07/2013
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
07/2013
1
MicroRNAs (MicroRNA)
IBA
07/2013
1
Nitric Oxide Synthase (NO Synthase)
IBA
02/2010
1
Dystrophin
IBA
04/2007
1
Nimodipine (Modus)
FDA Link
Generic
04/2004
1
Calcium Channel Blockers (Blockers, Calcium Channel)
IBA
04/2004
Therapy/Procedure
1
Therapeutics
01/2022